Loading company…
Metly provides pharmaceutical business development software for licensing and manufacturing opportunities.
Metly develops software for pharmaceutical business development teams, combining structured data, AI and market insights. Its platform includes a database of over 35,000 products and 500 sellers worldwide to support licensing and manufacturing decisions. In July 2025, it raised EUR 520,000 in pre-seed funding led by Encomenda Capital Partners, with Ona Capital and Dozen Investments participating. It plans to scale its technology and expand internationally, particularly in the US and China.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in